ORCID as entered in ROS

Select Publications
2020, 'Combined utility of blood glucose and white blood cell in predicting outcome after acute ischemic stroke: The ENCHANTED trial', Clinical Neurology and Neurosurgery, 198, http://dx.doi.org/10.1016/j.clineuro.2020.106254
,2020, 'Brain Imaging Signs and Health-Related Quality of Life after Acute Ischemic Stroke: Analysis of ENCHANTED Alteplase Dose Arm', Cerebrovascular Diseases, 49, pp. 427 - 436, http://dx.doi.org/10.1159/000509226
,2020, 'Utility-Weighted Modified Rankin Scale Scores for the Assessment of Stroke Outcome: Pooled Analysis of 20 000+ Patients', Stroke, 51, pp. 2411 - 2417, http://dx.doi.org/10.1161/STROKEAHA.119.028523
,2020, 'Ethnicity and Other Determinants of Quality of Functional Outcome in Acute Ischemic Stroke: The ENCHANTED Trial', Stroke, 51, pp. 588 - 593, http://dx.doi.org/10.1161/STROKEAHA.119.027639
,2020, 'Thrombolysis Outcomes in Acute Ischemic Stroke by Fluid-Attenuated Inversion Recovery Hyperintense Arteries', Stroke, 51, pp. 2240 - 2243, http://dx.doi.org/10.1161/STROKEAHA.119.028550
,2020, 'Abstract TMP15: Asian versus Non-Asian, Differences in Characteristics, Management & Outcomes in the Enchanted Trial', Stroke, 51, http://dx.doi.org/10.1161/str.51.suppl_1.tmp15
,2019, 'Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial', Lancet, 393, pp. 877 - 888, http://dx.doi.org/10.1016/S0140-6736(19)30038-8
,2019, 'Abstract TP362: Comparison of the Simplified Modified Rankin Scale Questionnaire With Conventional Neurological Scales in the Dose Arm of the Enchanted Study', Stroke, 50, http://dx.doi.org/10.1161/str.50.suppl_1.tp362
,2018, 'Statistical analysis plan for evaluating different intensities of blood pressure control in the ENhanced Control of Hypertension And Thrombolysis strokE stuDy.', International Journal of Stroke, pp. 1 - 4, http://dx.doi.org/10.1177/1747493018806170
,2017, 'Characteristics, management and response to alteplase in China versus non-China participants of the ENCHANTED trial', Stroke and Vascular Neurology, 2, pp. 53 - 58, http://dx.doi.org/10.1136/svn-2017-000085
,2017, 'Intracerebral hemorrhage location and outcome among INTERACT2 participants', Neurology, 88, pp. 1408 - 1414, http://dx.doi.org/10.1212/WNL.0000000000003771
,2017, 'Associations with health-related quality of life after intracerebral haemorrhage: Pooled analysis of INTERACT studies', Journal of Neurology Neurosurgery and Psychiatry, 88, pp. 70 - 75, http://dx.doi.org/10.1136/jnnp-2016-314414
,2016, 'Low-dose versus standard-dose intravenous alteplase in acute ischemic stroke', New England Journal of Medicine, 374, pp. 2313 - 2323, http://dx.doi.org/10.1056/NEJMoa1515510
,2016, 'White blood cell count and clinical outcomes after intracerebral hemorrhage: The INTERACT2 trial', Journal of the Neurological Sciences, 361, pp. 112 - 116, http://dx.doi.org/10.1016/j.jns.2015.12.033
,2015, 'Statistical analysis plan for evaluating low- vs. Standard-dose alteplase in the ENhanced Control of Hypertension and Thrombolysis strokE stuDy (ENCHANTED)', International Journal of Stroke, 10, pp. 1313 - 1315, http://dx.doi.org/10.1111/ijs.12602
,2015, 'Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2×2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment', International Journal of Stroke, 10, pp. 778 - 788, http://dx.doi.org/10.1111/ijs.12486
,2014, 'Subarachnoid extension of intracerebral hemorrhage and 90-day outcomes in INTERACT2', Stroke, 45, pp. 258 - 260, http://dx.doi.org/10.1161/Strokeaha.113.003524
,2019, 'Baseline brain imaging signs and outcomes in the ENCHANTED trial', in INTERNATIONAL JOURNAL OF STROKE, SAGE PUBLICATIONS LTD, pp. 7 - 7
,2017, 'Impact of Disparities in Acute Stroke Care Between High and Middle Income Countries', in CEREBROVASCULAR DISEASES, KARGER, pp. 2 - 3, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000415238400006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'The Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED): Complexity of Set-Up Large International Clinical Trial', in CEREBROVASCULAR DISEASES, KARGER, pp. 20 - 20, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000323941400047&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Intensive Ambulance-delivered Blood Pressure Reduction In Hyper-acute Stroke Trial', in CEREBROVASCULAR DISEASES, KARGER, Manila, Philippines, Vol. 48, pp. 111 - 111, presented at APSC 2019, Manila, Philippines, 02 October 2019
,2019, 'Thrombolysis outcomes in acute ischemic stroke by FLAIR hyper intense arteries', in INTERNATIONAL JOURNAL OF STROKE, SAGE PUBLICATIONS LTD, Vol. 14, pp. 6 - 7, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000485243200021&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Comparison of the Simplified Modified Rankin Scale Questionnaire With Conventional Neurological Scales in the Dose Arm of the Enchanted Study.', in STROKE, LIPPINCOTT WILLIAMS & WILKINS, HI, Honolulu, Vol. 50, presented at American-Heart-Association/American-Stroke-Association International Stroke Conference / State-of-the-Science Stroke Nursing Symposium, HI, Honolulu, 06 February 2019 - 08 February 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000478733401093&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2025, Optimizing blood pressure in acute intracerebral hemorrhage: protocol for a prospective individual participant data meta-analysis of the four INTERACT trials, http://dx.doi.org/10.1101/2025.03.03.25323285
,